Business

DEP irinotecan outperforms irinotecan in cancer models

DEP irinotecan outperforms irinotecan in cancer models

articleStarpharma Holdings LimitedJune 5, 20173/company/starpharma-holdings-ltd/news/dep-irinotecan-outperforms-irinotecan-in-cancer-models
DEP irinotecan outperforms irinotecan in cancer models

About this update from Starpharma Holdings Limited

[{"type":"text","content":"Starpharma Holdings Ltd has released a press release. View Attachment","length":237,"tagName":"div"}]

More updates from Starpharma Holdings Limited